Please login or register to print this page.


Articles tagged ‘NOACs’

February 21, 2017

Atrial fibrillation and CKD

Chronic kidney disease (CKD), however we measure it, “signifies poor outcomes in atrial fibrillation patients”. This was a key message from Dr Ami Banerjee (University College London). Drawing on recent European Society of Cardiology guidelines,1 he outlined how atrial fibrillation (AF) is present in 15–20% of CKD patients (10–20 times higher than the general population). These patients have an increased stroke rate, and there is also a higher risk of bleeding in CKD. The big question in terms of non-valvular AF and kidney disease is: how are they related?

read more

October 30, 2015

Drugs and devices – European Society of Cardiology highlights

A record-breaking meeting of the European Society of Cardiology (ESC) was held in London this year with 33,000 delegates from all over the world attending the five-day congress from 29th August–2nd September 2015. The British Journal of Cardiology (BJC) presents highlights from the meeting in their report, and in an accompanying podcast.

read more

July 30, 2015

Huge variation in use of new anticoagulants “completely unacceptable”

There is huge variation across England in the use of non-vitamin K antagonist oral anticoagulants (NOACs) to reduce stroke risk in patients with atrial fibrillation (AF), according to a recent statement from the Atrial Fibrillation Association (AF Association) which condemns the new data as “completely unacceptable”.1

read more

June 26, 2015

Pharmacist monitoring improves adherence to NOACs

Adherence to dabigatran treatment varies between Veterans Health Administration sites, among nonvalvular atrial fibrillation patients treated with dabigatran, according to a study published recently in the Journal of the American Medical Association.1

read more

May 28, 2015

NOAC news

The National Institute for Health and Care Excellence (NICE) has issued Final Appraisal Determination (FAD) recommending the NOAC (non-vitamin K oral anticoagulant) apixaban (Eliquis®) as an option for the treatment and prevention of recurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) in adults.

read more

April 29, 2015

Global AF treatment market to peak in 2020

The global market for atrial fibrillation (AF) treatment will more than double in value from $4.6 billion in 2013 to peak sales of $9.4 billion in 2020, before declining to $5.7 billion by 2023 as novel oral anticoagulants (NOACs) become genericised, according to a recent report from research and consulting firm GlobalData.1

read more

January 29, 2015

Meta-analysis confirms less bleeding risk with new oral anticoagulants

When compared with vitamin K antagonists (VKAs) administered to a target INR of 2.0 to 3.0, target-specific oral anticoagulants (TSOACs) are associated with less major bleeding, fatal bleeding, intracranial bleeding, clinically relevant non-major bleeding, and total bleeding, according to a study published recently in Blood.1

read more

September 26, 2014

Oral Anticoagulation Management Update Day

An ‘Oral anticoagulation management update day,’ which aims to provide an update on current developments focussing on the introduction of new oral anticoagulants, will be held on Wednesday 1st October 2014 at the Holiday Inn, Birmingham City Centre.

read more

June 26, 2014

Thousands of AF strokes avoidable, says NICE update

Thousands of people with atrial fibrillation (AF) suffer strokes, disability or death which are avoidable, according to new guidance published by the National institute for Health and Care Excellence (NICE) and produced by the National Clinical Guideline Centre.

read more

May 28, 2014

NOAC advice for surgical patients

An overview of the major clinical trials and recommendations related to new oral anticoagulants, which aims to serve as a practical guide for their use in patients who require planned or emergency surgery, has been published recently in the British Journal of Surgery.1

read more

Older articles »

Members Area

Log in or Register now.

 For healthcare professionals only
Learning sky



Subscribe to our RSS feed


Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.


    None Found


  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.